These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 10697276)

  • 1. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ; Bailey D; Marks A
    Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
    Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
    Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
    Fukunaga M
    Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
    Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
    Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
    Miettinen M; Lindenmayer AE; Chaubal A
    Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
    Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
    Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
    Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
    J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic implication of Kaposi's sarcoma-associated herpesvirus with special reference to the distinction between spindle cell hemangioendothelioma and Kaposi's sarcoma.
    Hisaoka M; Hashimoto H; Iwamasa T
    Arch Pathol Lab Med; 1998 Jan; 122(1):72-6. PubMed ID: 9448021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W; Mikami T; Masuzawa M; Okayasu I
    Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
    Miettinen M; Fetsch JF
    Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemangioendothelioma.
    Requena L; Kutzner H
    Semin Diagn Pathol; 2013 Feb; 30(1):29-44. PubMed ID: 23327728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
    Folpe AL; Chand EM; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.